Stockscreener 앱 받기
1.32
7.04%
-0.10
시간 외 거래:
1.40
0.08
+6.06%
전일 마감가:
$1.42
열려 있는:
$1.4
하루 거래량:
140.96K
Relative Volume:
0.02
시가총액:
$6.59M
수익:
-
순이익/손실:
$-11.66M
주가수익비율:
-0.1618
EPS:
-8.156
순현금흐름:
$-11.09M
1주 성능:
-15.92%
1개월 성능:
-35.29%
6개월 성능:
-50.00%
1년 성능:
-84.69%
1일 변동 폭
$1.31
$1.43
1주일 범위
$1.31
$1.61
52주 변동 폭
$1.31
$10.35
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
명칭
Phio Pharmaceuticals Corp
전화
(508) 767-3861
주소
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
PHIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
1.32 | 6.59M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-05 | 개시 | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Can Phio's Novel siRNA Cancer Technology Impress Investors at Upcoming Roadshow? - StockTitan
PHIO stock touches 52-week low at $1.48 amid market challenges - Investing.com
PHIO stock touches 52-week low at $1.48 amid market challenges By Investing.com - Investing.com South Africa
Brokers Offer Predictions for PHIO FY2024 Earnings - Defense World
Comparing Tharimmune (NASDAQ:THAR) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Phio Pharmaceuticals Appoints David Deming to Board - TipRanks
Phio Pharmaceuticals expands board with new director By Investing.com - Investing.com Nigeria
Phio Pharmaceuticals Corp. Appoints David H. Deming to Board of Directors -February 20, 2025 at 09:54 am EST - Marketscreener.com
H.C. Wainwright maintains Buy rating, $4 target on Phio Pharma stock - Investing.com
Phio Pharmaceuticals expands board with new director - Investing.com
Healthcare Finance Veteran With 30-Year Wall Street Track Record Takes Seat on Phio's BoardHere's Why It Matters - StockTitan
Phio Pharmaceuticals (NASDAQ:PHIO) Given “Buy” Rating at HC Wainwright - Defense World
PHIO Stock: The Biotech Breakthrough You Can't Ignore! Is This the Future of Immunotherapy? - Elblog.pl
Reviewing BridgeBio Pharma (NASDAQ:BBIO) & Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 5.8% – Should You Sell? - Defense World
Phio Pharma (NASDAQ:PHIO) Stock Quotes, Forecast and News Summary - Benzinga
Inside Phio's Revolutionary siRNA Cancer Treatment: CEO Reveals Clinical Progress - StockTitan
Revolutionary Cancer Treatment or Environmental Savior? - Elblog.pl
Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis - MarketBeat
Phio Pharmaceuticals CEO to Present Breakthrough Cancer Treatment at Renmark Virtual Roadshow - StockTitan
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio Pharmaceuticals Secures $1.83M Direct Offering to Advance Cancer Treatment Pipeline - StockTitan
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN
Phio Pharmaceuticals Raises $1.83M in Direct Offering with Warrant Coverage at $3.00/Share - StockTitan
Stock market news: Phio Pharmaceuticals +50.19%, DatChat +46.01% among top gainers during mid day trading - Business Upturn
Stock market today: Phio Pharmaceuticals -20.76%, Soligenix -20.15% among biggest losers in early trading - Business Upturn
Phio Pharmaceuticals Raises $2.5M Through Direct Offering at $3.00 Per Share - StockTitan
Phio Pharmaceuticals sharply lower on equity offering - MSN
Stock market news: Phio Pharmaceuticals -50.61%, Salarius Pharmaceuticals -28.61% among biggest losers during mid day trading - Business Upturn
Stock market news: Eterna Therapeutics posted gain of 100.87% while Phio Pharmaceuticals saw loss of 50.44% during mid day trading - Business Upturn
What's Going On With Phio Pharmaceuticals Stock Today? - Benzinga
Stock market today: Phio Pharmaceuticals -41.48%, Aehr Test Systems -26.86% among biggest losers in early trading - Business Upturn
Stock market today: Eterna Therapeutics gain over 136.63% while Phio Pharmaceuticals plunged by 40.25% in early trading - Business Upturn
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December - Benzinga
Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio stock surged 330%: Phio reports 100% tumor clearance - Markets.com
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside - newschannelnebraska.com
Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN
Phio Pharmaceuticals skyrockets on skin cancer drug trial success - Mugglehead
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. ... more inside - openPR
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge - Benzinga
Unlocking the Surge! Phio Pharmaceuticals Surprises Everyone with 300% Stock Surge - Elblog.pl
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On MondayHere's Why - Benzinga
Stock market news: Phio Pharmaceuticals +296.88%, Salarius Pharmaceuticals +153.67% among top gainers during mid day trading - Business Upturn
Stock market news: Shallgo saw rise of 286.81% while Kairos Pharma was up by 176.47% during mid day trading - Business Upturn
Stocks to Watch in 2025: PHIO, LPTH, KAVL and more - Markets.com
Phio Pharmaceuticals Corp (PHIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Phio Pharmaceuticals Corp 주식 (PHIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bitterman Robert J | President & CEO |
Jun 06 '24 |
Buy |
0.75 |
1,000 |
750 |
19,990 |
6.45%
1.23%
자본화:
|
볼륨(24시간):